Ready-to-Use Dural Grafts: Gamma Sterilization and OR Workflow

A ready-to-use, gamma-sterilized dural graft reaches the sterile field in a few steps: the circulator checks the label, opens the package aseptically and passes the graft to the scrub team. There is no reprocessing and no assembly. For OR teams, the benefit is a simpler, more predictable workflow and a graft that is available the moment the surgeon asks.

Unit price is the number that appears on a purchasing spreadsheet, but in the operating room the cost of a product also includes the time and attention it takes to get it onto the field. This article looks at what "ready to use" and "gamma sterilized" mean in practice, using DESU's DURASHEET and DECOLL as the example, and how a distributor can present those features to OR leadership and value-analysis teams.

What does "ready to use" mean in the operating room?

For a dural graft, "ready to use" means the product is supplied sterile, in its final packaging, in a form the surgeon can use as described in the Instructions for Use. The OR team does not need to sterilize it, assemble it or prepare it in a separate area.

Both DESU dural membranes are described this way. DURASHEET is a suturable dural graft matrix usable on both surfaces, and DECOLL is a collagen dura membrane intended for onlay use. Each is made of pure Type I bovine collagen, comes in four sizes, and is supplied ready to use and gamma sterilized.

The IFU always has the final word. If it describes any handling step, such as how to position or trim the graft, the team follows it. "Ready to use" simply means there is no extra processing step between the shelf and the field.

Why does gamma sterilization matter to the OR team?

Gamma irradiation is a well-established method of terminal sterilization for medical devices. The product is sterilized after it is sealed in its packaging, so the sterile barrier stays intact until the package is opened in the OR. Radiation sterilization of health care products is governed by the ISO 11137 series, which covers the validation and routine control of the process.

For the OR team, three practical points follow:

• The graft arrives sterile and stays sterile as long as the package is intact and within its expiry date.
• There is no need to route it through the hospital's sterile processing department.
• The checks before opening are the standard ones: package integrity, expiry date, product and size, and the sterilization indicator on the label.

Storage is the other half of the picture. The package label states the storage conditions and the expiry date, and the hospital follows them. Because the product is sterilized in its final package, the shelf itself needs no special handling beyond what the label requires: keep packages dry, protected from damage, and rotated so that the earliest expiry is used first.

For the technical background, our article on gamma sterilization of collagen dura membranes goes into more detail.

What does the workflow look like from shelf to field?

The table below sets out a typical sequence for a ready-to-use dural graft. Local policies and the IFU take precedence; the point is to show how few steps are involved.

Recording the implant at the moment of opening, rather than after the case, matters more than it seems. Lot numbers on dural grafts are needed for traceability, and a label that is easy to read and to scan or peel into the record makes that step quick. Our article on dural graft traceability and storage covers what the record should contain.

Compare that with any product that requires preparation outside the field, a mixing step or a special storage condition that delays retrieval. Each extra step is a moment where the case waits and where errors can creep in.

Where is time usually lost with dural grafts?

In conversations with OR teams, the delays around dural grafts rarely come from the graft itself. They come from the logistics around it:

• The right size is not in the room, and someone has to fetch it from another core or another department.
• The graft is stored somewhere unusual, so the circulator has to search for it.
• The team is unsure which of two similar products the surgeon wants.
• A larger sheet is opened because the smaller one cannot be found, and most of it is discarded.
• The lot number has to be recorded after the case, from a package that has already been thrown away.

A ready-to-use product helps, but it does not solve these problems alone. The distributor can help by making sure the sizes the surgeons use are stocked where they operate, labeling the shelf clearly and training the team on the difference between the sutured and onlay products.

How does this help in unplanned cases?

Some of the most important dural graft cases are not planned. A spine surgeon may encounter a durotomy during a decompression. A trauma team may perform a decompressive procedure in the middle of the night. In both settings, the OR staff on duty may not be the regular neurosurgery team.

The night trauma case

A graft that is simply taken from the shelf, checked and opened is easier for a less familiar team to handle correctly. Clear shelf labels by product and size, and a one-page reference card, make it easier still.

The unexpected spinal tear

In spine rooms, the graft may be used only occasionally. A ready-to-use product with a straightforward opening sequence is less likely to cause confusion when it is needed. Stocking the sizes that suit spinal defects in that room avoids a long wait.

What should value analysis count besides price?

Value-analysis committees compare products on more than unit cost, and workflow features deserve a place in that comparison. Without inventing numbers, a committee can ask practical questions:

• Does the product require any preparation outside the sterile field?
• Does it require special storage that limits where it can be kept?
• How many sizes are available, and does the range reduce the need to open larger sheets?
• Is the same product family available for both sutured and onlay repair?
• How clear is the labeling for checking and recording the implant?
• How quickly can the supplier replace stock?

These questions bring the OR's experience into the decision. A nurse manager who has watched a case wait for a graft will often be the strongest voice for a product that simplifies the workflow.

How should a distributor present these features?

Workflow features are best demonstrated, not described. Bring a demonstration unit, show the package and the label, and walk the team through the sequence in the table above. Ask the circulators what slows them down today, and show how the product and a sensible size mix would help.

Avoid overstating the benefit. Do not claim the product shortens surgery or reduces complications; you have no data to support that. Say instead that it is supplied ready to use and gamma sterilized, that it needs no reprocessing, and that it is available in four sizes in two formats. Those facts are enough for an experienced OR team to draw its own conclusions.

A short in-service is often the most effective format. Fifteen minutes at the start of a shift, with the two products side by side, the size range on one card and a walk-through of the opening and recording steps, reaches the people who will actually handle the graft. Repeat it for night and weekend staff, who are the most likely to meet the product in an unplanned case. DESU's specialists can help prepare the material for these sessions.

Talk to a DESU product specialist

If you are a distributor working with OR leadership, or a hospital team reviewing dural graft workflow, DESU's product specialists can provide labeling samples, IFU and training material for DURASHEET and DECOLL, and discuss what your market requires. Contact sales@desu.tr, use the contact page, or request a quote.